The calcium channel blocking medicine market in Canada shows a clear declining trajectory from 2024 to 2028, with sales as a percentage of total sales dropping annually. The 2023 figure marks a critical reference point to understand that the forecasted decline begins immediately thereafter. Between 2024 to 2028, sales decrease by 57.1%, indicating a strong downward trend with a compound annual growth rate (CAGR) of -22.5% from 2024-2028.

Future trends to watch for:

Potential introduction of generic alternatives could further reduce market share.
Emerging therapies and changing medical guidelines might alter future demand.
An increase in healthcare awareness and lifestyle changes could impact long-term sales trends.